Crispr Therapeutics shares owned by Woodline Partners
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Woodline Partners
from 13F filings
Historical chart of Woodline Partners investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Woodline Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.3M | 144k | 64.81 |
| 2025-06-30 | $7.3M | 149k | 48.64 |
| 2025-03-31 | $4.6M | 137k | 34.03 |
| 2024-12-31 | $4.0M | 102k | 39.36 |
| 2024-09-30 | $4.7M | 100k | 46.98 |
| 2024-06-30 | $6.9M | 127k | 54.01 |
| 2024-03-31 | $11M | 164k | 68.16 |
| 2023-09-30 | $4.6M | 100k | 45.39 |
| 2023-06-30 | $2.8M | 50k | 56.14 |
| 2022-03-31 | $12M | 189k | 62.77 |
| 2021-12-31 | $710k | 9.4k | 75.80 |